フルテキストファイル | |
著者 |
Wang Zhongzhi
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
Hasegawa Junichi
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
KAKEN
Wang Xinhui
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
Matsuda Akiko
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
KAKEN
Tokuda Takahiro
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
Miura Norimasa
Division of Pharmacotherapeutics, Department of Pathophysiological and Therapeutic Science, School of Medicine, Tottori University Faculty of Medicine
KAKEN
Watanabe Tatsuo
Division of Integrative Physiology, Department of Functional, Morphological and Regulatory Science, School of Medicine, Tottori University Faculty of Medicine
研究者総覧
KAKEN
|
キーワード | aspirin
gastric damage
ginger powder
inflammatory cytokine
inducible form of NO synthase activity
|
抄録 | We investigated the mechanism underlying the protective effects of ginger against gastric damage induced by aspirin in rats. Gastric mucosal lesions were produced by orally administering 200 mg/kg aspirin suspended in 1% carboxymethylcellulose solution to pyloric-ligated male Wistar rats. Ginger powder (200 mg/kg) markedly reduced the aspirin-induced gastric hemorrhagic ulcer area. The total acidity of gastric juice was not significantly influenced by aspirin or ginger. Ginger powder did not affect the aspirin-induced reduction in mucosal prostaglandin E2 (PGE2) content; however, it did ameliorate the aspirin-induced increases in mucosal activity of the inducible form of NO synthase (iNOS) and plasma tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels. In the next experiment, high and low doses of 6-gingerol and 6-shogaol were used instead of ginger powder in the same experimental model to examine their roles in the anti-ulcer mechanism of ginger. Both 6-gingerol and 6-shogaol reduced aspirin induced ulcer formation, mucosal iNOS and plasma TNF-α and IL-1β levels. In conclusion, ginger powder prevents the aspirin induced gastric ulcer formation by reducing mucosal iNOS activity and the plasma levels of inflammatory cytokines but does not affect gastric juice or acid production or mucosal PGE2 content. This protective effect of ginger powder against gastric ulcers may be attributable to both gingerol and shogaol.
|
出版者 | Tottori University Faculty of Medicine
|
資料タイプ |
学術雑誌論文
|
外部リンク | |
ISSN | 1346-8049
|
書誌ID | AA00892882
|
掲載誌名 | Yonago Acta medica
|
最新掲載誌名 |
Yonago Acta medica
|
巻 | 54
|
号 | 1
|
開始ページ | 11
|
終了ページ | 19
|
発行日 | 2011-03
|
著者版フラグ |
出版社版
|
著作権表記 | Yonago Acta medica 編集委員会
|
掲載情報 | Yonago Acta medica. 2011, 54(1), 11-19
|
部局名 |
医学部・医学系研究科・医学部附属病院
|
言語 |
英語
|